SDGRSchrödinger, Inc.

$935M

Q3 2022 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$37M+23.9% YoY

Gross Profit

$17M46.5% margin

Operating Income

-$46M-124.8% margin

Net Income

-$40M-107.8% margin

EPS (Diluted)

$-0.56

QoQ Revenue Growth

-3.9%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$33M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$662M

Total Liabilities

$199M

Stockholders' Equity

$463M

Cash & Equivalents

$103M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$37M	$30M	+23.9%
Gross Profit	$17M	$11M	+54.8%
Operating Income	-$46M	-$35M	-33.1%
Net Income	-$40M	-$35M	-13.8%

Revenue Segments

Software Products And Services

$25M25%

Revenue From Contract With Customer Before Contribution

$25M25%

On Premise Software

$13M13%

Drug Discovery

$12M12%

Drug Discovery Services Revenue From Contracts With Customers

$12M12%

Maintenance

$5M5%

Hosted Software

$4M4%

Professional Services

$3M3%

Drug Discovery Services

$2M2%

Geographic Segments

UNITED STATES

$27M74%

Europe

$4M10%

Non-US

$4M10%

JAPAN

$2M5%